UnitedHealth Group (UNH)
(Delayed Data from NYSE)
$577.96 USD
-11.18 (-1.90%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $578.87 +0.91 (0.16%) 7:22 PM ET
2-Buy of 5 2
B Value D Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$577.96 USD
-11.18 (-1.90%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $578.87 +0.91 (0.16%) 7:22 PM ET
2-Buy of 5 2
B Value D Growth C Momentum C VGM
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
UnitedHealth Group Incorporated (UNH) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to UnitedHealth (UNH). This makes it worthwhile to examine what the stock has in store.
Centene (CNC) Wins Medi-Cal Contracts but Loses 3 Counties
by Zacks Equity Research
Centene (CNC) is likely to appeal the decision to avoid disruption in services and it has time until Sep 1, 2022, to do so.
Should You Invest in the Vanguard Health Care ETF (VHT)?
by Zacks Equity Research
Sector ETF report for VHT
UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $541.57, marking a +0.95% move from the previous day.
3 Cash-Generating Machines in the S&P 500
by Derek Lewis
When scouting for strong stocks, free cash flow is a metric worth serious attention.
The Zacks Analyst Blog Highlights UnitedHealth Group, Adobe, Charles Schwab, Lowe's Companies and Analog Devices
by Zacks Equity Research
UnitedHealth Group, Adobe, Charles Schwab, Lowe's Companies and Analog Devices are included in this Analyst Blog.
Top Analyst Reports for UnitedHealth, Adobe & The Charles Schwab
by Sheraz Mian
Today's Research Daily features new research reports on 12 major stocks, including UnitedHealth Group Incorporated (UNH), Adobe Inc. (ADBE) and The Charles Schwab Corporation (SCHW).
UnitedHealth (UNH) Eyes Signify Health Acquisition: Here's Why
by Zacks Equity Research
UnitedHealth (UNH) is reportedly the highest bidder with more than $30 per share for Signify Health.
Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?
by Zacks Equity Research
Sector ETF report for PTH
UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $548.32, moving +0.57% from the previous trading session.
LHC Group (LHCG) to Expand Access in Georgia With New Buyout
by Zacks Equity Research
LHC Group (LHCG) is set to acquire Georgia-based Three Rivers Home Health that will expand its service footprint in 36 counties in the state of Georgia.
Investors Heavily Search UnitedHealth Group Incorporated (UNH): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching UnitedHealth (UNH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Humana (HUM) to Acquire Inclusa to Aid Medicaid Customer Base
by Zacks Equity Research
Humana (HUM) inks a deal to purchase Wisconsin-based Inclusa to grow its Medicaid membership and fortify its footprint in the state.
Pediatrix (MD) Up 8% Since Q2 Earnings Release, Revenues Up Y/Y
by Zacks Equity Research
Pediatrix's (MD) second-quarter results reflect growth in patient volumes. Adjusted EBITDA is expected within $260-$270 million for 2022.
UnitedHealth (UNH) Unit Adds Features to Surest Plans
by Zacks Equity Research
UnitedHealth Group's (UNH) arm UnitedHealthcare advances Surest plans by including features to lure more employers into opting for the attractive package and bolster its geographic reach.
Should Invesco Dividend Achievers ETF (PFM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for PFM
Should First Trust Rising Dividend Achievers ETF (RDVY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for RDVY
Ensign Group (ENSG) Stock Up 6% Since Q2 Earnings Release
by Zacks Equity Research
Ensign Group's (ENSG) second-quarter results reflect revenue growth, and solid contributions from the Skilled Services and Standard Bearer segments. A hiked 2022 EPS guidance bodes well.
Here is What to Know Beyond Why UnitedHealth Group Incorporated (UNH) is a Trending Stock
by Zacks Equity Research
UnitedHealth (UNH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Is Vanguard Dividend Appreciation ETF (VIG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for VIG
Humana (HUM) Q2 Earnings Beat Estimates, Ups '22 EPS View
by Zacks Equity Research
Humana's (HUM) second-quarter earnings benefit from higher premiums and strong individual Medicare Advantage membership growth. A hiked adjusted EPS guidance for 2022 is noteworthy.
Is First Trust Rising Dividend Achievers ETF (RDVY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RDVY
Universal Health (UHS) Q2 Earnings Beat on Strong Segments
by Zacks Equity Research
Universal Health's (UHS) second-quarter results benefit from strong contributions from Acute Care Hospital Services and Behavioral Health Care Services segments, partly offset by elevated operating costs.
Should Vanguard Value ETF (VTV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VTV
Tenet Healthcare (THC) Q2 Earnings Beat, Trims '22 EPS View
by Zacks Equity Research
Tenet Healthcare's (THC) second-quarter earnings benefit from strong Ambulatory Care and Conifer segments. However, a trimmed EPS view for 2022 might raise concerns for investors.